Tolerance Bio Lands Second Clinical Deal, Building the Broadest Clinical-Stage Thymus Pipeline
Key Highlights Every person’s thymus, the organ that trains the immune system, shrinks with age, and as it fades the body becomes more vulnerable to infection, cancer and autoimmune disease. Tolerance Bio has now secured what it calls the broadest pipeline aimed at slowing, stopping and reversing that loss. The Philadelphia biotech has licensed TLB-33, […]